Dietary Supplement of n-3 PUFA to Control Corneal Inflammation
Dietary Supplement of n-3 PUFA to Control Corneal Inflammation
批准号:
10393908
负责人:
Dimitrios Karamichos
金额:
$15.31万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-05-31
关键词:
3-DimensionalAreaBlindnessBurn injuryCeramidesChemicalsChronicCicatrixComplexContact LensesCorneaCorneal AbrasionCorneal DiseasesCorneal InjuryCorneal NeovascularizationCorneal OpacityCorneal dystrophyDataDevelopmentDietDietary SupplementationDocosahexaenoic AcidsDue ProcessEconomicsEicosapentaenoic AcidEquilibriumExtracellular MatrixEyeFDA approvedFeedbackFibroblastsFibrosisFish OilsG-Protein-Coupled ReceptorsGTP-Binding Protein alpha Subunits, GsGeneticGenetic DiseasesGenetic TranscriptionHumanInfectionInflammationInvestigationKeratoconusKeratoplastyKnock-outMediator of activation proteinMetabolismMusMyofibroblastN-3 polyunsaturated fatty acidOperative Surgical ProceduresOralOutcomePathologicPathway interactionsPatientsPharmaceutical PreparationsPhenotypePlayProcessProtein IsoformsPuncture woundResearchResolutionRoleSPHK1 enzymeSignal PathwaySignal TransductionSiteSphingolipidsSphingosineSphingosine-1-Phosphate ReceptorStromal CellsSystemic diseaseTestingTherapeuticTissuesTranscriptional ActivationTransforming Growth Factor beta ReceptorsTransforming Growth FactorsTranslatingTransplantation SurgeryTraumaUnited States National Institutes of HealthUp-RegulationWild Type Mousecorneal epithelial wound healingcorneal regenerationcorneal scardietary supplementseffective therapyfibrogenesishealinghuman diseaseimprovedin vitro Modelin vivoinhibitor/antagonistlipid mediatormigrationmouse modelneovascularizationnew therapeutic targetnovelparent grantpreventreceptorresponsesight restorationsmall molecule inhibitorsphingosine 1-phosphatetherapeutic developmentwound healing
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Title: Dietary Supplement of n-3 PUFA to Control Corneal Inflammation
Abstract: Cornea being the outer most tissue in the eye suffers regular injuries from corneal abrasions, puncture
wounds, chemical and thermal burns that induce corneal inflammation. Corneal inflammation is also integral to
genetic diseases like keratoconus, long-term wearing of contact lenses, and surgical corneal transplantation.
Imbalances in inflammation and improper wound-healing (resolution) causes corneal scar and
neovascularization (NV) that leads to blindness. Up to one fourth of all cases of blindness worldwide are
attributable to corneal opacities generated by scarring, or fibrosis, representing a huge economic and societal
burden. The primary cause of corneal fibrosis development is defective wound healing process due to
imbalances in the inflammation and its resolution. Currently, there is no FDA-approved drug that facilitates proper
corneal wound healing. We hypothesize that n-3 polyunsaturated fatty acids (PUFAs) from Fish Oil dietary
supplementation will inhibit corneal fibrosis and NV by reducing chronic inflammation and augmenting
resolution and wound-healing.
During inflammation and tissue healing, it is the N-3 PUFAs (such as eicosapentaenoic acid, EPA, and
docosahexaenoic acid, DHA) that generates several bioactive lipid mediators (such as resolvins, neuroprotectins
and maresins) that play essential roles in resolution of inflammation and tissue healing. Although substantial
research data is available regarding the benefits of n-3 PUFAs (DHA and EPA) in many human systemic
diseases, the role of n-3 PUFAs in corneal healing and restoration of vision has not been studied. We propose
to determine the efficacy of dietary supplementation of n-3 PUFA from OmegaRx2 Fish Oil (Zone Labs)
to prevent corneal scar and NV in mouse model of corneal injuries. We anticipate our study will ultimately
translate in to human augmentative dietary supplement of n-3 PUFAs to help balance the inflammation and
improve the resolution and wound-healing in the corneas that are prone to develop scar and NV due to underlying
genetic causes, contact lens wearing or corneal transplantation surgery and thus will prevent formation of
permanent scar and blindness.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
The Intimate Interplay Between Keratoconus, Sex Hormones, and the Anterior Pituitary
-
批准号:10746247
-
项目类别:
-
资助金额:$39.35万
-
财政年份:2023
-
负责人:Dimitrios Karamichos
-
依托单位:
The role of extracellular vesicles in keratoconus pathogenesis
-
批准号:10595121
-
项目类别:
-
资助金额:$22.2万
-
财政年份:2023
-
负责人:Dimitrios Karamichos
-
依托单位:
The Impact of Prolactin Induced Protein in Corneal Wound Healing and Fibrosis
-
批准号:10747116
-
项目类别:
-
资助金额:$47.74万
-
财政年份:2023
-
负责人:Dimitrios Karamichos
-
依托单位:
Sphingolipids and their Impact in Corneal Wound Healing
-
批准号:10405111
-
项目类别:
-
资助金额:$39.32万
-
财政年份:2020
-
负责人:Dimitrios Karamichos
-
依托单位:
Sphingolipids and their Impact in Corneal Wound Healing
-
批准号:10197933
-
项目类别:
-
资助金额:$39.25万
-
财政年份:2020
-
负责人:Dimitrios Karamichos
-
依托单位:
Sphingolipids and their Impact in Corneal Wound Healing
-
批准号:10298908
-
项目类别:
-
资助金额:$6.15万
-
财政年份:2020
-
负责人:Dimitrios Karamichos
-
依托单位:
Sphingolipids and their Impact in Corneal Wound Healing
-
批准号:10626104
-
项目类别:
-
资助金额:$40.54万
-
财政年份:2020
-
负责人:Dimitrios Karamichos
-
依托单位:
Utility of PIP as a Novel Keratoconus Biomarker
-
批准号:10018023
-
项目类别:
-
资助金额:$30.18万
-
财政年份:2019
-
负责人:Dimitrios Karamichos
-
依托单位:
Utility of PIP as a Novel Keratoconus Biomarker
-
批准号:10245081
-
项目类别:
-
资助金额:$29.42万
-
财政年份:2019
-
负责人:Dimitrios Karamichos
-
依托单位:
Utility of PIP as a Novel Keratoconus Biomarker
-
批准号:10653013
-
项目类别:
-
资助金额:$37.0万
-
财政年份:2019
-
负责人:Dimitrios Karamichos
-
依托单位:
Utility of PIP as a Novel Keratoconus Biomarker
-
批准号:10439888
-
项目类别:
-
资助金额:$35.89万
-
财政年份:2019
-
负责人:Dimitrios Karamichos
-
依托单位:
Utility of PIP as a Novel Keratoconus Biomarker
-
批准号:10723125
-
项目类别:
-
资助金额:$4.8万
-
财政年份:2019
-
负责人:Dimitrios Karamichos
-
依托单位:
A Novel Pathogenic Pathway for Diabetic Keratopathy
-
批准号:10548571
-
项目类别:
-
资助金额:$4.71万
-
财政年份:2018
-
负责人:Dimitrios Karamichos
-
依托单位:
A Novel Pathogenic Pathway for Diabetic Keratopathy
-
批准号:9764374
-
项目类别:
-
资助金额:$29.0万
-
财政年份:2018
-
负责人:Dimitrios Karamichos
-
依托单位:
Sex Hormones and Keratoconus
-
批准号:9490094
-
项目类别:
-
资助金额:$36.25万
-
财政年份:2018
-
负责人:Dimitrios Karamichos
-
依托单位:
A Novel Pathogenic Pathway for Diabetic Keratopathy
-
批准号:10006074
-
项目类别:
-
资助金额:$24.29万
-
财政年份:2018
-
负责人:Dimitrios Karamichos
-
依托单位:
Sex Hormones and Keratoconus
-
批准号:9915927
-
项目类别:
-
资助金额:$36.5万
-
财政年份:2018
-
负责人:Dimitrios Karamichos
-
依托单位:
A Novel Pathogenic Pathway for Diabetic Keratopathy
-
批准号:10602957
-
项目类别:
-
资助金额:$39.08万
-
财政年份:2018
-
负责人:Dimitrios Karamichos
-
依托单位:
Sphingolipid signaling in corneal wound healing and fibrosis
-
批准号:8859937
-
项目类别:
-
资助金额:$23.68万
-
财政年份:2015
-
负责人:Dimitrios Karamichos
-
依托单位:
Sphingolipid signaling in corneal wound healing and fibrosis
-
批准号:9042372
-
项目类别:
-
资助金额:$19.23万
-
财政年份:2015
-
负责人:Dimitrios Karamichos
-
依托单位:
国内基金
海外基金
层出镰刀菌氮代谢调控因子AreA 介导伏马菌素 FB1 生物合成的作用机理
-
批准号:2021JJ40433
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2021
-
负责人:孙磊
-
依托单位:
寄主诱导梢腐病菌AreA和CYP51基因沉默增强甘蔗抗病性机制解析
-
批准号:32001603
-
项目类别:青年科学基金项目
-
资助金额:24.0万元
-
批准年份:2020
-
负责人:段真珍
-
依托单位:
AREA国际经济模型的移植.改进和应用
-
批准号:18870435
-
项目类别:面上项目
-
资助金额:2.0万元
-
批准年份:1988
-
负责人:史树中
-
依托单位: